Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

TERUMO BCT, INC.

Filed by TERUMO BCT, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 20, 2026
Income
Not reported
Expenses
$20,000.00
Filing UUID
d0022de2-0a37-4dba-b2a0-a95c2334e2fb
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

TRD · Trade (domestic/foreign)

Global trade and tariffs

HCR · Health Issues

S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Blood and cell collection, storage, and processing Blood donation supply and quality

Literal federal measure citations: S.735, H.R. 1796

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.